Genisphere Licenses 3DNA Dendrimer Signal Amplification Technology to Chembio Diagnostics, Inc. for Lateral Flow Rapid Test Applications

Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

HATFIELD, Pa.--(BUSINESS WIRE)--Genisphere LLC has licensed its 3DNA® Signal Amplification technology to Chembio Diagnostics, Inc., a leader in point-of-care ("POC") diagnostic tests for infectious diseases. Chembio plans to use the signal enhancing technology for its Dual Path Platform (“DPP®”) rapid diagnostic pipeline tests, with the goal of achieving detection limits unique to rapid immunoassays thereby broadening potential applications of its technology by combining it with the Genisphere technology.

Help employers find you! Check out all the jobs and post your resume.

Back to news